Vyvanse Generics Roll Out — And Disappoint
https://adhdrollercoaster.org/adhd-medications/vyvanse-generics-on-the-way/
WebDec 14, 2023 · Japan-based Takeda acquired Vyvanse from Shire in 2019. Even before that, though, Shire took legal actions to prevent competitors from entering the market until the Vyvanse patent expired in 2023. In the U.S., Vyvanse generated substantial revenue for Takeda—to the tune of $2.53 billion in 2022, showing impressive growth over the …
DA: 40 PA: 60 MOZ Rank: 46